ALY688-SR (Allysta Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameALY688-SR (Allysta Pharmaceuticals)
Drug Alias NameALY-688 (Allysta Pharmaceuticals)sustained release formulation of ALY-688 (Allysta Pharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAdiponectin receptors agonists
TargetsAdiponectin receptors
Therapy Area/IndicationsFibrosisHeart FailureMetabolic Dysfunction-Associated Steatotic Liver Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllysta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAllysta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsFibrosisHeart FailureMetabolic Dysfunction-Associated Steatotic Liver Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A